Literature DB >> 31126178

Mean Platelet Volume and Major Adverse Cardiac Events following Percutaneous Coronary Intervention.

Younes Nozari1, Maziar Parsa1, Arash Jalali1, Hamid Ariannejad1, Akbar Shafiee1.   

Abstract

BACKGROUND: Mean platelet volume (MPV) has been introduced as a simple and accurate method for assessing platelet function, which can be used as a prognostic marker for cardiovascular events. We investigated whether pre-procedural MPV could predict major adverse cardiac events (MACE) in candidates for elective percutaneous coronary intervention (PCI).
METHODS: In this large retrospective cohort, we reviewed the clinical and follow-up data of 4199 candidates (mean age = 59.9 ± 10.3 years; female patients = 1440 [34.3%]) for elective PCI due to unstable angina (UA) or non-ST segment elevation myocardial infarction (NSTEMI). The primary endpoint of the study was the incidence of MACE defined as in-hospital mortality, cardiac death, nonfatal MI, target lesion revascularization (TLR) or target vessel revascularization (TVR). Based on the MPV level tertiles, patients were categorized into three groups for further comparison.
RESULTS: Higher MPV was significantly associated with older age (P<0.001), hypertension (P<0.001), diabetes mellitus (P=0.003), history of previous CABG (P<0.001) and lower levels of serum triglyceride (P<0.001). The frequency of 1-year MACE was 176 (4.1%) with no significant difference between the MPV tertile groups. The highest MPV tertile could significantly predict MACE in the univariable model (hazard ratio = 1.51, 95% confidence interval: 1.05-2.17; P=0.026). In the adjusted model, the highest MPV tertile was a borderline predictor for MACE (hazard ratio = 1.62, 95% CI: 0.98-2.68; P=0.057).
CONCLUSION: High MPV was associated with cardiovascular risk factors and older age while high MPV was a borderline independent predictor for 1-year MACE in the candidates for elective PCI.
© 2019 The Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Entities:  

Keywords:  Coronary artery disease; Major adverse cardiac events; Mean platelet volume; Non-ST elevation myocardial infarction; Percutaneous coronary intervention; Platelet count

Year:  2019        PMID: 31126178

Source DB:  PubMed          Journal:  Arch Iran Med        ISSN: 1029-2977            Impact factor:   1.354


  2 in total

1.  Mean Platelet Volume is Associated with Pancreatic β-Cell Dysfunction in Nondiabetic Patients with Coronary Artery Disease.

Authors:  Xiliang Zhao; Xiaoli Li; Quan Li; Yicong Ye; Yong Zeng
Journal:  Int J Gen Med       Date:  2021-10-05

2.  The White Blood Cell Count to Mean Platelet Volume Ratio for the Prediction of Chronic Limb-Threatening Ischemia in Lower Extremity Artery Disease.

Authors:  Katharina Guetl; Reinhard Bernd Raggam; Viktoria Muster; Paul Gressenberger; Jovan Vujic; Alexander Avian; Franz Hafner; Martin Wehrschuetz; Marianne Brodmann; Thomas Gary
Journal:  J Clin Med       Date:  2019-10-02       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.